Blue Biofuels director sells 500K shares at $0.10

Director Chris J Kneppers disclosed open-market sales totaling 500,000 BIOF shares at $0.10 per share across two September 2026 transactions.

Rhea-AI Filing Summary

BLUE BIOFUELS, INC. (BIOF) director Chris J Kneppers reported two open-market sales of common stock. On September 4, 2026, he sold 200,000 shares at $0.10 per share, followed by a sale of 300,000 shares at $0.10 per share on September 8, 2026. No Rule 10b5-1 trading plan is reported. A remark states that 18,972,677 shares are held jointly with Angela Kneppers.

Insider Trade Summary

Net Seller: 500,000 shares

Net Sell 2 txns

Insider Kneppers Chris J

Role Director

Sold 500,000 shs ($50K)

Type	Security	Shares	Price	Value
Sale	Common Stock	300,000	$0.10	$30K
Sale	Common Stock	200,000	$0.10	$20K

Holdings After Transaction: Common Stock — 19,972,677 shares (Direct)

Key Figures

Shares sold on September 4, 2026: 200,000 shares Shares sold on September 8, 2026: 300,000 shares Total shares sold in reported transactions: 500,000 shares +2 more

5 metrics

Shares sold on September 4, 2026 200,000 shares Sale of BLUE BIOFUELS, INC. common stock at $0.10 per share

Shares sold on September 8, 2026 300,000 shares Sale of BLUE BIOFUELS, INC. common stock at $0.10 per share

Total shares sold in reported transactions 500,000 shares Aggregate of two sales reported in the Form 4

Sale price per share $0.10 per share Price for both September 4 and September 8, 2026 sales

Jointly held shares 18,972,677 shares Shares held jointly with Angela Kneppers as noted in the remarks

Key Terms

open market or private transaction, Rule 10b5-1, ten percent owner

3 terms

open market or private transaction market

"transaction is described as a "Sale in open market or private transaction""

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

ten percent owner regulatory

"Form 4 identifies whether the reporting person is a ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BIOF director Chris J Kneppers report in this Form 4?

He reported two sales of BLUE BIOFUELS, INC. common stock: 200,000 shares on September 4, 2026 and 300,000 shares on September 8, 2026, both at $0.10 per share, in open-market or private transactions.

How many BLUE BIOFUELS (BIOF) shares did Chris J Kneppers sell in total?

Across the reported transactions, Chris J Kneppers sold a total of 500,000 shares of BLUE BIOFUELS, INC. common stock, consisting of 200,000 shares on September 4, 2026 and 300,000 shares on September 8, 2026.

At what price were the BIOF shares sold by Chris J Kneppers?

Both reported sales were executed at $0.10 per share, with 200,000 shares sold at that price on September 4, 2026 and 300,000 shares sold at the same price on September 8, 2026.

Does this BIOF Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 plan is reported for these transactions, meaning they are not affirmed as having been executed under a pre-arranged trading plan.

How many BLUE BIOFUELS (BIOF) shares are noted as jointly held by Chris J Kneppers?

A remark in the filing states that 18,972,677 shares of BLUE BIOFUELS, INC. common stock are held jointly with Angela Kneppers. The Form 4 does not provide a post-transaction total holdings figure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 08:29 PM Accepted by SEC EDGAR 09/08/2026 - 08:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kneppers Chris J

(Last) (First) (Middle)

8 BETHPAGE DRIVE

(Street)

SKILLMAN NEW JERSEY 08558

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BLUE BIOFUELS, INC. [ BIOF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		S		200,000	D	$0.1	20,272,677	D
Common Stock	09/08/2026		S		300,000	D	$0.1	19,972,677	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

18,972,677 shares are held jointly with Angela Kneppers.

	/s/ Chris Kneppers	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)